POS0775 RITUXIMAB ASSOCIATED WITH A DECREASED RISK OF LUPUS NEPHRITIS FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS Article Swipe

View

T.J. Lee , Ting‐Yuan Lan , I. Parodis , Saparna Pai , Cheng‐Hsien Lu , Chen‐Yang Shen , Kejun Li , S. C. Hsieh , Y K Onno Teng ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1016/j.ard.2025.06.135

Related Topics

Concepts

Medicine Lupus nephritis Rituximab Immunology Systemic lupus erythematosus Nephritis Belimumab Lupus erythematosus Dermatology Internal medicine Antibody B-cell activating factor Disease B cell

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.ard.2025.06.135
OA Status: hybrid
Cited By: 1
Related Works: 10
OpenAlex ID: https://openalex.org/W4411415254

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4411415254

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.ard.2025.06.135

Digital Object Identifier
Title: POS0775 RITUXIMAB ASSOCIATED WITH A DECREASED RISK OF LUPUS NEPHRITIS FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-06-01

Full publication date if available
Authors: T.J. Lee, Ting‐Yuan Lan, I. Parodis, Saparna Pai, Cheng‐Hsien Lu, Chen‐Yang Shen, Kejun Li, S. C. Hsieh, Y K Onno Teng

List of authors in order
Landing page: https://doi.org/10.1016/j.ard.2025.06.135

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: hybrid

Open access status per OpenAlex
OA URL: https://doi.org/10.1016/j.ard.2025.06.135

Direct OA link when available
Concepts: Medicine, Lupus nephritis, Rituximab, Immunology, Systemic lupus erythematosus, Nephritis, Belimumab, Lupus erythematosus, Dermatology, Internal medicine, Antibody, B-cell activating factor, Disease, B cell

Top concepts (fields/topics) attached by OpenAlex
Cited by: 1

Total citation count in OpenAlex
Citations by year (recent): 2025: 1

Per-year citation counts (last 5 years)
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4411415254
doi	https://doi.org/10.1016/j.ard.2025.06.135
ids.doi	https://doi.org/10.1016/j.ard.2025.06.135
ids.openalex	https://openalex.org/W4411415254
fwci	6.0153987
type	article
title	POS0775 RITUXIMAB ASSOCIATED WITH A DECREASED RISK OF LUPUS NEPHRITIS FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
biblio.issue
biblio.volume	84
biblio.last_page	935
biblio.first_page	934
topics[0].id	https://openalex.org/T10308
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9994000196456909
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2745
topics[0].subfield.display_name	Rheumatology
topics[0].display_name	Systemic Lupus Erythematosus Research
topics[1].id	https://openalex.org/T11330
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9969000220298767
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2734
topics[1].subfield.display_name	Pathology and Forensic Medicine
topics[1].display_name	Systemic Sclerosis and Related Diseases
topics[2].id	https://openalex.org/T11834
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9909999966621399
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2721
topics[2].subfield.display_name	Hepatology
topics[2].display_name	Liver Diseases and Immunity
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9609251618385315
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C2779912601
concepts[1].level	3
concepts[1].score	0.8193347454071045
concepts[1].wikidata	https://www.wikidata.org/wiki/Q1621830
concepts[1].display_name	Lupus nephritis
concepts[2].id	https://openalex.org/C2780653079
concepts[2].level	3
concepts[2].score	0.7119093537330627
concepts[2].wikidata	https://www.wikidata.org/wiki/Q412323
concepts[2].display_name	Rituximab
concepts[3].id	https://openalex.org/C203014093
concepts[3].level	1
concepts[3].score	0.5688637495040894
concepts[3].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[3].display_name	Immunology
concepts[4].id	https://openalex.org/C2776912625
concepts[4].level	3
concepts[4].score	0.5561773777008057
concepts[4].wikidata	https://www.wikidata.org/wiki/Q1485
concepts[4].display_name	Systemic lupus erythematosus
concepts[5].id	https://openalex.org/C2777058396
concepts[5].level	2
concepts[5].score	0.46661868691444397
concepts[5].wikidata	https://www.wikidata.org/wiki/Q401402
concepts[5].display_name	Nephritis
concepts[6].id	https://openalex.org/C2781205201
concepts[6].level	5
concepts[6].score	0.45025575160980225
concepts[6].wikidata	https://www.wikidata.org/wiki/Q1996249
concepts[6].display_name	Belimumab
concepts[7].id	https://openalex.org/C2775915377
concepts[7].level	3
concepts[7].score	0.4494193196296692
concepts[7].wikidata	https://www.wikidata.org/wiki/Q188297
concepts[7].display_name	Lupus erythematosus
concepts[8].id	https://openalex.org/C16005928
concepts[8].level	1
concepts[8].score	0.3679823875427246
concepts[8].wikidata	https://www.wikidata.org/wiki/Q171171
concepts[8].display_name	Dermatology
concepts[9].id	https://openalex.org/C126322002
concepts[9].level	1
concepts[9].score	0.2754659354686737
concepts[9].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[9].display_name	Internal medicine
concepts[10].id	https://openalex.org/C159654299
concepts[10].level	2
concepts[10].score	0.21354946494102478
concepts[10].wikidata	https://www.wikidata.org/wiki/Q79460
concepts[10].display_name	Antibody
concepts[11].id	https://openalex.org/C170286685
concepts[11].level	4
concepts[11].score	0.07319211959838867
concepts[11].wikidata	https://www.wikidata.org/wiki/Q409346
concepts[11].display_name	B-cell activating factor
concepts[12].id	https://openalex.org/C2779134260
concepts[12].level	2
concepts[12].score	0.06583443284034729
concepts[12].wikidata	https://www.wikidata.org/wiki/Q12136
concepts[12].display_name	Disease
concepts[13].id	https://openalex.org/C2778453870
concepts[13].level	3
concepts[13].score	0.0
concepts[13].wikidata	https://www.wikidata.org/wiki/Q188930
concepts[13].display_name	B cell
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9609251618385315
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/lupus-nephritis
keywords[1].score	0.8193347454071045
keywords[1].display_name	Lupus nephritis
keywords[2].id	https://openalex.org/keywords/rituximab
keywords[2].score	0.7119093537330627
keywords[2].display_name	Rituximab
keywords[3].id	https://openalex.org/keywords/immunology
keywords[3].score	0.5688637495040894
keywords[3].display_name	Immunology
keywords[4].id	https://openalex.org/keywords/systemic-lupus-erythematosus
keywords[4].score	0.5561773777008057
keywords[4].display_name	Systemic lupus erythematosus
keywords[5].id	https://openalex.org/keywords/nephritis
keywords[5].score	0.46661868691444397
keywords[5].display_name	Nephritis
keywords[6].id	https://openalex.org/keywords/belimumab
keywords[6].score	0.45025575160980225
keywords[6].display_name	Belimumab
keywords[7].id	https://openalex.org/keywords/lupus-erythematosus
keywords[7].score	0.4494193196296692
keywords[7].display_name	Lupus erythematosus
keywords[8].id	https://openalex.org/keywords/dermatology
keywords[8].score	0.3679823875427246
keywords[8].display_name	Dermatology
keywords[9].id	https://openalex.org/keywords/internal-medicine
keywords[9].score	0.2754659354686737
keywords[9].display_name	Internal medicine
keywords[10].id	https://openalex.org/keywords/antibody
keywords[10].score	0.21354946494102478
keywords[10].display_name	Antibody
keywords[11].id	https://openalex.org/keywords/b-cell-activating-factor
keywords[11].score	0.07319211959838867
keywords[11].display_name	B-cell activating factor
keywords[12].id	https://openalex.org/keywords/disease
keywords[12].score	0.06583443284034729
keywords[12].display_name	Disease
language	en
locations[0].id	doi:10.1016/j.ard.2025.06.135
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S25650217
locations[0].source.issn	0003-4967, 1468-2060
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0003-4967
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of the Rheumatic Diseases
locations[0].source.host_organization	https://openalex.org/P4310319945
locations[0].source.host_organization_name	BMJ
locations[0].source.host_organization_lineage	https://openalex.org/P4310319945
locations[0].source.host_organization_lineage_names	BMJ
locations[0].license	cc-by-nc-nd
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc-nd
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of the Rheumatic Diseases
locations[0].landing_page_url	https://doi.org/10.1016/j.ard.2025.06.135
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5055556699
authorships[0].author.orcid
authorships[0].author.display_name	T.J. Lee
authorships[0].author_position	first
authorships[0].raw_author_name	T.J. Lee
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5062692833
authorships[1].author.orcid	https://orcid.org/0000-0002-2827-1692
authorships[1].author.display_name	Ting‐Yuan Lan
authorships[1].author_position	middle
authorships[1].raw_author_name	T.Y. Lan
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5011649002
authorships[2].author.orcid
authorships[2].author.display_name	I. Parodis
authorships[2].author_position	middle
authorships[2].raw_author_name	I. Parodis
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5027632335
authorships[3].author.orcid	https://orcid.org/0000-0003-1571-3997
authorships[3].author.display_name	Saparna Pai
authorships[3].author_position	middle
authorships[3].raw_author_name	S.Y. Pai
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5034295849
authorships[4].author.orcid	https://orcid.org/0000-0002-5716-3930
authorships[4].author.display_name	Cheng‐Hsien Lu
authorships[4].author_position	middle
authorships[4].raw_author_name	C.H. Lu
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5006076332
authorships[5].author.orcid	https://orcid.org/0000-0001-5555-9950
authorships[5].author.display_name	Chen‐Yang Shen
authorships[5].author_position	middle
authorships[5].raw_author_name	C.Y. Shen
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5100633719
authorships[6].author.orcid
authorships[6].author.display_name	Kejun Li
authorships[6].author_position	middle
authorships[6].raw_author_name	K.J. Li
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5113617528
authorships[7].author.orcid
authorships[7].author.display_name	S. C. Hsieh
authorships[7].author_position	middle
authorships[7].raw_author_name	S. Hsieh
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5081323703
authorships[8].author.orcid	https://orcid.org/0000-0001-9920-2195
authorships[8].author.display_name	Y K Onno Teng
authorships[8].author_position	last
authorships[8].raw_author_name	Y.K.O. Teng
authorships[8].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1016/j.ard.2025.06.135
open_access.oa_status	hybrid
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	POS0775 RITUXIMAB ASSOCIATED WITH A DECREASED RISK OF LUPUS NEPHRITIS FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10308
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9994000196456909
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2745
primary_topic.subfield.display_name	Rheumatology
primary_topic.display_name	Systemic Lupus Erythematosus Research
related_works	https://openalex.org/W3037530918, https://openalex.org/W4386519366, https://openalex.org/W3199695429, https://openalex.org/W4320717373, https://openalex.org/W2021597875, https://openalex.org/W4410325613, https://openalex.org/W4398233414, https://openalex.org/W4229335325, https://openalex.org/W4226190572, https://openalex.org/W4224247022
cited_by_count	1
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	1
locations_count	1
best_oa_location.id	doi:10.1016/j.ard.2025.06.135
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S25650217
best_oa_location.source.issn	0003-4967, 1468-2060
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0003-4967
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Annals of the Rheumatic Diseases
best_oa_location.source.host_organization	https://openalex.org/P4310319945
best_oa_location.source.host_organization_name	BMJ
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310319945
best_oa_location.source.host_organization_lineage_names	BMJ
best_oa_location.license	cc-by-nc-nd
best_oa_location.pdf_url
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc-nd
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Annals of the Rheumatic Diseases
best_oa_location.landing_page_url	https://doi.org/10.1016/j.ard.2025.06.135
primary_location.id	doi:10.1016/j.ard.2025.06.135
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S25650217
primary_location.source.issn	0003-4967, 1468-2060
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0003-4967
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of the Rheumatic Diseases
primary_location.source.host_organization	https://openalex.org/P4310319945
primary_location.source.host_organization_name	BMJ
primary_location.source.host_organization_lineage	https://openalex.org/P4310319945
primary_location.source.host_organization_lineage_names	BMJ
primary_location.license	cc-by-nc-nd
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc-nd
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of the Rheumatic Diseases
primary_location.landing_page_url	https://doi.org/10.1016/j.ard.2025.06.135
publication_date	2025-06-01
publication_year	2025
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year.max	95
cited_by_percentile_year.min	91
countries_distinct_count	0
institutions_distinct_count	9
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.7400000095367432
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.89997975
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	True